Who We HelpOur ScienceProductsOutcomes
Log InAskSequence your genome↗
Traits
Traits linked to CLCN2
chloride voltage-gated channel 2
The Human Phenotype Ontology links 37 traits to CLCN2, by body system: features seen in people with one of the gene's rare conditions.
Who We HelpOur ScienceProductsOutcomes
Log InAskSequence your genome↗
Who We HelpOur ScienceProductsOutcomes
Log InAskSequence your genome↗
Abnormality of the nervous system
| Trait | How often it is seen |
|---|---|
| Limb ataxia | Always |
| EEG with polyspike wave complexes | Very often (80–99%) |
| Generalized-onset seizure | Very often (80–99%) |
| Morning myoclonic jerks | Very often (80–99%) |
| Action tremor | Often (30–79%) |
| Headache | Often (30–79%) |
| Inability to coordinate movements when walking | Often (30–79%) |
| Brief seizures with staring spells | Sometimes (5–29%) |
| Febrile seizure (within the age range of 3 months to 6 years) | Sometimes (5–29%) |
| Generalized myoclonic seizure | Sometimes (5–29%) |
| Photosensitive tonic-clonic seizure | Sometimes (5–29%) |
| Aggressive behavior | Rarely (1–4%) |
| Repeated seizures without recovery between them | Rarely (1–4%) |
| Intellectual disability | Not recorded |
| Leukoencephalopathy | Not recorded |
| Morning generalized tonic-clonic seizures | Not recorded |
Abnormality of the endocrine system
| Trait | How often it is seen |
|---|---|
| Abnormal circulating renin | Very often (80–99%) |
| Glucocortocoid-insensitive primary hyperaldosteronism | Very often (80–99%) |
| Secretory adrenocortical adenoma | Often (30–79%) |
| Enlarged adrenal glands | Sometimes (5–29%) |
| Dexamethasone-suppressible primary hyperaldosteronism | Not recorded |
| Elevated plasma aldosterone | Not recorded |
Abnormality of the eye
| Trait | How often it is seen |
|---|---|
| Abnormality of eye movement | Often (30–79%) |
| Damaged optic nerve | Often (30–79%) |
| Partial loss of field of vision | Often (30–79%) |
| Chorioretinal atrophy | Sometimes (5–29%) |
| Choroidal neovascularization | Sometimes (5–29%) |
| Retinoschisis | Sometimes (5–29%) |
Abnormality of blood and blood-forming tissues
| Trait | How often it is seen |
|---|---|
| Bleeding within the skull | Sometimes (5–29%) |
| Bloody nose | Sometimes (5–29%) |
Laboratory abnormality
| Trait | How often it is seen |
|---|---|
| Low blood potassium levels | Always |
| Metabolic alkalosis | Sometimes (5–29%) |
Abnormality of head or neck
| Trait | How often it is seen |
|---|---|
| Abnormality of the mouth | Often (30–79%) |
Abnormality of the cardiovascular system
| Trait | How often it is seen |
|---|---|
| High blood pressure | Always |
Abnormality of the digestive system
| Trait | How often it is seen |
|---|---|
| Nausea | Sometimes (5–29%) |
Abnormality of the ear
| Trait | How often it is seen |
|---|---|
| Ringing in ears | Sometimes (5–29%) |
Abnormality of the musculoskeletal system
| Trait | How often it is seen |
|---|---|
| Muscle weakness | Sometimes (5–29%) |
How often is among people with one of the gene's conditions, the most often across them, as the Human Phenotype Ontology records it. These pages describe traits and the research behind them; they are not a diagnosis, and a doctor or genetic counsellor is the person to ask about symptoms.
Where this comes from
- The Human Phenotype Ontology, release 2026-09-01: the traits linked to CLCN2 and how often each is seen. Find out more at hpo.jax.org.
Who We HelpOur ScienceProductsOutcomes
Log InAskSequence your genome↗
One test. A lifetime of answers.
From $449Free shipping · Results in 6–8 weeks